Literature DB >> 3262486

Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects.

S Nagai1, M Takeuchi, K Watanabe, H Aung, T Izumi.   

Abstract

To evaluate the activation of alveolar macrophages from smoking, we studied interleukin-1 (IL-1) activity released from alveolar macrophages in eight healthy smokers, compared to 12 healthy nonsmokers. We used 24-hour culture supernatants containing IL-1 of bronchoalveolar lavage fluid (BALF) macrophages/blood monocytes with or without LPS stimulation. Using C3H/HeJ thymocyte PHA costimulation assay, we found that IL-1 activity released from LPS stimulated BALF macrophages was significantly higher in smokers (2.39 +/- 0.33 U/ml) than in nonsmokers (1.47 +/- 0.19 U/ml, p less than 0.05). We also detected IL-1 inhibitory activity in supernatants by using IL-1 inhibitory assay. The inhibitory activity was higher in nonsmokers than in smokers especially under LPS stimulation. The presence of inhibitory factors other than prostaglandin-E2 was suggested from the differential response to the addition of indomethacin into cultures from nonstimulated and LPS-stimulated supernatants of BALF macrophages.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262486     DOI: 10.1378/chest.94.4.694

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Effects of cigarette smoke and asbestos on airway, vascular and mesothelial cell proliferation.

Authors:  H Sekhon; J Wright; A Churg
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

2.  Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  Synergistic effects of mineral fibres and cigarette smoke on the production of tumour necrosis factor by alveolar macrophages of rats.

Authors:  Y Morimoto; M Kido; I Tanaka; A Fujino; T Higashi; Y Yokosaki
Journal:  Br J Ind Med       Date:  1993-10

4.  Acute effects of smoking and high experimental exposure to environmental tobacco smoke (ETS) on the immune system.

Authors:  S Hockertz; A Emmendörffer; G Scherer; T Ruppert; H Daube; A R Tricker; F Adlkofer
Journal:  Cell Biol Toxicol       Date:  1994-06       Impact factor: 6.691

5.  Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist.

Authors:  M Takeuchi; S Nagai; H Nakada; H Aung; N Satake; H Kaneshima; T Izumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).

Authors:  J Kadota; Y Matsubara; Y Ishimatsu; M Ashida; K Abe; R Shirai; K Iida; K Kawakami; H Taniguchi; T Fujii; M Kaseda; S Kawamoto; S Kohno
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

Review 7.  Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Authors:  Giuseppe Lopalco; Luca Cantarini; Antonio Vitale; Florenzo Iannone; Maria Grazia Anelli; Laura Andreozzi; Giovanni Lapadula; Mauro Galeazzi; Donato Rigante
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

Review 8.  Are healthy smokers really healthy?

Authors:  Zijing Zhou; Ping Chen; Hong Peng
Journal:  Tob Induc Dis       Date:  2016-11-15       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.